BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience
Business Of Biotech - Ein Podcast von Matt Pillar - Montags

Kategorien:
We love to hear from our listeners. Send us a message. From the JP Morgan Healthcare Conference in San Francisco, Dr. Stefan Scherer shares insight from 3T Bioscience's transition from clinical medicine to drug development, and his experiences in biotech leadership along the way. Dr. Scherer discusses the balance between promising advances in T-cell therapy and the challenges associated with navigating a biotech from platform development to lead candidate status -- including staffing up for ...